149 related articles for article (PubMed ID: 12193596)
1. Rhizobium sin-1 lipopolysaccharide (LPS) prevents enteric LPS-induced cytokine production.
Vandenplas ML; Carlson RW; Jeyaretnam BS; McNeill B; Barton MH; Norton N; Murray TF; Moore JN
J Biol Chem; 2002 Nov; 277(44):41811-6. PubMed ID: 12193596
[TBL] [Abstract][Full Text] [Related]
2. The 2-aminogluconate isomer of rhizobium sin-1 lipid A can antagonize TNF-alpha production induced by enteric LPS.
Lee HS; Wolfert MA; Zhang Y; Boons GJ
Chembiochem; 2006 Jan; 7(1):140-8. PubMed ID: 16317789
[TBL] [Abstract][Full Text] [Related]
3. Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid.
Vasan M; Wolfert MA; Boons GJ
Org Biomol Chem; 2007 Jul; 5(13):2087-97. PubMed ID: 17581652
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.
Perera PY; Qureshi N; Christ WJ; Stütz P; Vogel SN
Infect Immun; 1998 Jun; 66(6):2562-9. PubMed ID: 9596717
[TBL] [Abstract][Full Text] [Related]
5. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of Rhizobium sin-1 lipid A derivatives.
Demchenko AV; Wolfert MA; Santhanam B; Moore JN; Boons GJ
J Am Chem Soc; 2003 May; 125(20):6103-12. PubMed ID: 12785841
[TBL] [Abstract][Full Text] [Related]
7. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma.
Aida Y; Kusumoto K; Nakatomi K; Takada H; Pabst MJ; Maeda K
J Leukoc Biol; 1995 Dec; 58(6):675-82. PubMed ID: 7499965
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
9. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.
Golenbock DT; Hampton RY; Qureshi N; Takayama K; Raetz CR
J Biol Chem; 1991 Oct; 266(29):19490-8. PubMed ID: 1918061
[TBL] [Abstract][Full Text] [Related]
10. Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide.
Ulmer AJ; Feist W; Heine H; Kirikae T; Kirikae F; Kusumoto S; Kusama T; Brade H; Schade U; Rietschel ET
Infect Immun; 1992 Dec; 60(12):5145-52. PubMed ID: 1280625
[TBL] [Abstract][Full Text] [Related]
11. A novel lipid A from Halomonas magadiensis inhibits enteric LPS-induced human monocyte activation.
Ialenti A; Di Meglio P; Grassia G; Maffia P; Di Rosa M; Lanzetta R; Molinaro A; Silipo A; Grant W; Ianaro A
Eur J Immunol; 2006 Feb; 36(2):354-60. PubMed ID: 16365914
[TBL] [Abstract][Full Text] [Related]
12. Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS.
Jarvis BW; Lichenstein H; Qureshi N
Infect Immun; 1997 Aug; 65(8):3011-6. PubMed ID: 9234747
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of a lipid A derivative that contains an aminogluconate moiety.
Santhanam B; Wolfert MA; Moore JN; Boons GJ
Chemistry; 2004 Oct; 10(19):4798-807. PubMed ID: 15372693
[TBL] [Abstract][Full Text] [Related]
14. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel lipid-A from Rhizobium species Sin-1. A unique lipid-A structure that is devoid of phosphate and has a glycosyl backbone consisting of glucosamine and 2-aminogluconic acid.
Jeyaretnam B; Glushka J; Kolli VS; Carlson RW
J Biol Chem; 2002 Nov; 277(44):41802-10. PubMed ID: 12193590
[TBL] [Abstract][Full Text] [Related]
16. Preparation of a lipid a derivative that contains a 27-hydroxyoctacosanoic acid moiety.
Santhanam B; Boons GJ
Org Lett; 2004 Sep; 6(19):3333-6. PubMed ID: 15355045
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
Mathison JC; Tobias PS; Wolfson E; Ulevitch RJ
J Immunol; 1992 Jul; 149(1):200-6. PubMed ID: 1607653
[TBL] [Abstract][Full Text] [Related]
18. The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation.
Müller M; Scheel O; Lindner B; Gutsmann T; Seydel U
J Endotoxin Res; 2003; 9(3):181-6. PubMed ID: 12831460
[TBL] [Abstract][Full Text] [Related]
19. Glucose phosphorylated on carbon 6 suppresses lipopolysaccharide binding to lipopolysaccharide-binding protein and inhibits its bioactivities.
Fujita Y; Yagi K
Int Immunopharmacol; 2017 Apr; 45():43-52. PubMed ID: 28187312
[TBL] [Abstract][Full Text] [Related]
20. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction.
Kirikae T; Schade FU; Zähringer U; Kirikae F; Brade H; Kusumoto S; Kusama T; Rietschel ET
FEMS Immunol Med Microbiol; 1994 Jan; 8(1):13-26. PubMed ID: 8156049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
